Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 257

1.

Paradoxes of senolytics.

Blagosklonny MV.

Aging (Albany NY). 2018 Dec 28;10(12):4289-4293. doi: 10.18632/aging.101750. No abstract available.

2.

Rapamycin, proliferation and geroconversion to senescence.

Blagosklonny MV.

Cell Cycle. 2018 Dec 12:1-11. doi: 10.1080/15384101.2018.1554781. [Epub ahead of print]

PMID:
30541374
3.

Disease or not, aging is easily treatable.

Blagosklonny MV.

Aging (Albany NY). 2018 Nov 17;10(11):3067-3078. doi: 10.18632/aging.101647.

4.

Does rapamycin slow down time?

Blagosklonny MV.

Oncotarget. 2018 Jul 13;9(54):30210-30212. doi: 10.18632/oncotarget.25788. eCollection 2018 Jul 13. No abstract available.

5.

A parthenogenetic quasi-program causes teratoma-like tumors during aging in wild-type C. elegans.

Wang H, Zhao Y, Ezcurra M, Benedetto A, Gilliat AF, Hellberg J, Ren Z, Galimov ER, Athigapanich T, Girstmair J, Telford MJ, Dolphin CT, Zhang Z, Gems D.

NPJ Aging Mech Dis. 2018 Jun 13;4:6. doi: 10.1038/s41514-018-0025-3. eCollection 2018.

6.

Correction: Librarians against scientists: Oncotarget's lesson.

Blagosklonny MV.

Oncotarget. 2018 Mar 13;9(19):15167. doi: 10.18632/oncotarget.24692. eCollection 2018 Mar 13.

7.

Librarians against scientists: Oncotarget's lesson.

Blagosklonny MV.

Oncotarget. 2018 Jan 19;9(5):5515-5516. doi: 10.18632/oncotarget.24272. eCollection 2018 Jan 19. No abstract available. Erratum in: Oncotarget. 2018 Mar 13;9(19):15167.

8.

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G.

Cell Death Differ. 2018 Mar;25(3):486-541. doi: 10.1038/s41418-017-0012-4. Epub 2018 Jan 23. Review.

9.

While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts.

Leontieva OV, Blagosklonny MV.

Oncotarget. 2017 May 11;8(65):109848-109856. doi: 10.18632/oncotarget.17827. eCollection 2017 Dec 12.

10.

From rapalogs to anti-aging formula.

Blagosklonny MV.

Oncotarget. 2017 May 30;8(22):35492-35507. doi: 10.18632/oncotarget.18033. Review.

11.

Gerosuppression by pan-mTOR inhibitors.

Leontieva OV, Blagosklonny MV.

Aging (Albany NY). 2016 Dec 30;8(12):3535-3551. doi: 10.18632/aging.101155.

12.

Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).

Leontieva OV, Demidenko ZN, Blagosklonny MV.

Oncotarget. 2015 Sep 15;6(27):23238-48.

13.

Energy excess is the main cause of accelerated aging of mammals.

Biliński T, Paszkiewicz T, Zadrag-Tecza R.

Oncotarget. 2015 May 30;6(15):12909-19.

14.

Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats.

Lesovaya EA, Kirsanov KI, Antoshina EE, Trukhanova LS, Gorkova TG, Shipaeva EV, Salimov RM, Belitsky GA, Blagosklonny MV, Yakubovskaya MG, Chernova OB.

Oncotarget. 2015;6(12):9718-27.

15.

Rejuvenating immunity: "anti-aging drug today" eight years later.

Blagosklonny MV.

Oncotarget. 2015 Aug 14;6(23):19405-12.

16.

Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion.

Leontieva OV, Blagosklonny MV.

Oncotarget. 2014 Dec 30;5(24):12715-27.

17.

Gerosuppression in confluent cells.

Leontieva OV, Blagosklonny MV.

Aging (Albany NY). 2014 Dec;6(12):1010-8.

18.

Fasting levels of hepatic p-S6 are increased in old mice.

Leontieva OV, Paszkiewicz GM, Blagosklonny MV.

Cell Cycle. 2014;13(17):2656-9. doi: 10.4161/15384101.2014.949150.

19.

Comparison of rapamycin schedules in mice on high-fat diet.

Leontieva OV, Paszkiewicz GM, Blagosklonny MV.

Cell Cycle. 2014;13(21):3350-6. doi: 10.4161/15384101.2014.970491.

20.

Geroconversion: irreversible step to cellular senescence.

Blagosklonny MV.

Cell Cycle. 2014;13(23):3628-35. doi: 10.4161/15384101.2014.985507. Review.

Supplemental Content

Loading ...
Support Center